Cargando…
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
BACKGROUND: Methotrexate is an immunomodulatory therapy that may offer benefit to patients with hidradenitis suppurativa (HS). Despite its theoretical advantages, there is a paucity of available data regarding long-term methotrexate use in patients with HS. OBJECTIVE: This study aimed to assess whet...
Autores principales: | Savage, Kevin T., Brant, Elena Gonzalez, Rosales Santillan, Monica, Morss, Peyton C., Salian, Prerna, Flood, Kelsey S., Porter, Martina L., Kimball, Alexa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330449/ https://www.ncbi.nlm.nih.gov/pubmed/32637536 http://dx.doi.org/10.1016/j.ijwd.2020.02.007 |
Ejemplares similares
-
Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020) -
Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022) -
TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019) -
Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study
por: Kim, Diana S., et al.
Publicado: (2022) -
Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)